Clinical Trial Update: Precision Medicine With Zibotentan in Microvascular Angina [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on zibotentan for microvascular angina has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Angina

Drugs mentioned

• Zibotentan (zibotentan)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Microvascular Angina | Phase 2 | Status: COMPLETED